Considering that Bevacizumab (a monoclonal antibody against VEGF) was approved for GBM treatment, Verhoeff et al. investigated the effect of aptamer-based anti-VEGF treatment in combination with irradiation in an orthotopic mouse model of GBM. This evidence concerns the gene VEGFA and glioblastoma.